Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxcarbazepine for impulsivity and aggression in conduct disorder
NCT00154362Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of oxcarbazepine in conduct disorder (CD), sponsored by Novartis. Started Apr 2003; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
conduct disorder (CD)
Beyond the preview
Go deeper on NCT00154362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154362.